Interestingly, patients with PTEN hamartoma tumor syndromes are at higher risk for both aforementioned tumor entities (cumulative cancer risk at age 70: 77% for female breast cancer and 38% for thyroid cancer) [25]. This evidence concerns the gene PTEN and breast cancer.